Fette Tablet Press Designed for High Production

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-10-02-2014
Volume 38
Issue 10

Fette Compacting America FE75 Tablet Press is designed to produce up to 1.6 million tablets per hour.

Fette Compacting America’s FE75 Tablet Press can be equipped with up to 115 punch stations to produce more than 1.6 million tablets per hour. The FE75 features four compression rollers with a control system for direct compression, enabling the machine to operate with two intermediate pressures.

The system measures two square meters, with a double-sided rotary press to allow users to press single- and double-layer tablets and powder. The FE75 includes pneumatically controlled tablet scrapers, conical filling units, tubeless extraction unit, and chassis complete with a two-part frame structure and a pneumatic suspension system.

Fette Compacting America
www.fetteamerica.com

Articles in this issue
Ross-856927-1416898025646.jpg
Ross Agitated Vessel Includes Silicone Heating Blankets
Analytical Method Comparability in Registration and Post-Approval Stages: A Risk-Based Approach
Analytical Method Comparability in Registration and Post-Approval Stages: A Risk-Based Approach
Wechsler_Jill-856790-1416898146268.jpg
Biopharma Manufacturers Respond to Ebola Crisis
Determining Facility Mold Infection
romacokilianktp-856928-1416898023256.jpg
Romaco Kilian's Tablet Press Introduces Continuous Weight Control
GEA-856930-1416898019279.jpg
GEA Pharma Systems Valves Contain Powders
figure1-856883-1417773790013.jpg
Packaging Addresses Cold-Chain Requirements
Fluorination Remains Key Challenge in API Synthesis
Fluorination Remains Key Challenge in API Synthesis
Fette-856929-1416898021360.jpg
Fette Tablet Press Designed for High Production
Marrying Big Data with Personalized Medicine
Marrying Big Data with Personalized Medicine
Morris_marilyn-856679-1416897342957.jpg
Bolstering Graduate Education and Research Programs
Solving Poor Solubility with Amorphous Solid Dispersions
Solving Poor Solubility with Amorphous Solid Dispersions
The Role of Normal Data Distribution in Pharmaceutical Development and Manufacturing
The Role of Normal Data Distribution in Pharmaceutical Development and Manufacturing
Milmo_Sean-856903-1416898033486.jpg
Harmonizing Marketing Approval of Generic Drugs in Europe
AlphaG-gd-858224-1416895790953.jpg
Meissner's Filtration System Allows Scalability
Recent Videos
Behind the Headlines episode 6
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

CDMO SEKISUI Expands its CGMP Biopharma Manufacturing Capacity

Feliza Mirasol
November 20th 2024
Article

SEKISUI has used a £15.7 million (US$20.7 million) investment to expand its clinical-grade drug substance manufacturing at its UK site.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Frontier Scientific Solutions Plans a Global Free Trade Zone Gateway to Supply Life Sciences Industry on Back of $1.5 Billion Investment

Feliza Mirasol
November 16th 2024
Article

Frontier Scientific Solutions has unveiled plans to use a $1.5 billion commitment from a major investor to create a global free trade zone gateway to facilitate the life sciences supply chain using Wilmington International Airport in North Carolina.

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

March 26th 2024
Podcast

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Avantor Sees Future of Opportunities with Growing Development of Next-Gen Biotherapeutics

Feliza Mirasol
November 15th 2024
Article

Executives at Avantor talk about the future of the biopharmaceutical industry and the anticipated impact that a wave of next-generation biotherapeutics will bring.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Merck and Ginkgo Bioworks’ Collaboration to Improve Biologics Manufacturing Has Reached Its First Milestone

Feliza Mirasol
November 13th 2024
Article

Under an ongoing partnership with Merck, known as MSD outside of the United States and Canada, Ginkgo Bioworks has achieved the first milestone in a project aimed at improving biologics production.